Showing results (11-20 of 57) with videos related to
Sort By:
Pageof 6
Cancer Research|April 2, 2017
<i>ATM</i> Deficiency Is Associated with Sensitivity to PARP1- and ATR Inhibitors in Lung AdenocarcinomaAnna Schmitt, Gero Knittel, Daniela Welcker, et al.Plos One|May 21, 2015
Label-Free Protein-RNA Interactome Analysis Identifies Khsrp Signaling Downstream of the p38/Mk2 Kinase Complex as a Critical Modulator of Cell Cycle ProgressionJorge Boucas, Christian Fritz, Anna Schmitt, et al.Nature Communications|September 18, 2020
mTOR-mediated cancer drug resistance suppresses autophagy and generates a druggable metabolic vulnerabilityNiklas Gremke, Pierfrancesco Polo, Aaron Dort, et al.Journal of Medical Internet Research|February 15, 2023
A New Option for Pain Prevention Using a Therapeutic Virtual Reality Solution for Bone Marrow Biopsy (REVEH Trial): Open-Label, Randomized, Multicenter, Phase 3 StudyKatell Le Du, Anne-Lise Septans, Frédéric Maloisel, et al.Journal of Hematology & Oncology|September 19, 2024
Phase IB part of LOC-R01, a LOC network non-comparative randomized phase IB/II study testing R-MPV in combination with escalating doses of lenalidomide or ibrutinib for newly diagnosed primary central nervous system lymphoma (PCNSL) patientsMarion Alcantara, Marion Chevrier, Fabrice Jardin, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 6, 2010
Methotrexate Reduces the Incidence of Severe Acute Graft-versus-Host Disease without Increasing the Risk of Relapse after Reduced-Intensity Allogeneic Stem Cell Transplantation from Unrelated DonorsStéphane Vigouroux, Reza Tabrizi, Cyril Melot, et al.Experimental Hematology|May 26, 2018
Long-term follow-up of de novo chronic phase chronic myelogenous leukemia patients on front-line imatinibFranck Emmanuel Nicolini, Vincent Alcazer, Pascale Cony-Makhoul, et al.Cancer Research|August 14, 2019
Dual Inhibition of GLUT1 and the ATR/CHK1 Kinase Axis Displays Synergistic Cytotoxicity in <i>KRAS</i>-Mutant Cancer CellsJohanna Erber, Joachim D Steiner, Jörg Isensee, et al.American Journal of Hematology|October 9, 2014
ELN 2013 response status criteria: relevance for de novo imatinib chronic phase chronic myeloid leukemia patients?Gabriel Etienne, Stéphanie Dulucq, Axelle Lascaux, et al.Scientific Reports|November 16, 2017
Targeting a non-oncogene addiction to the ATR/CHK1 axis for the treatment of small cell lung cancerFabian Doerr, Julie George, Anna Schmitt, et al.Pageof 6